RESEARCH STATS
POOL
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
Interactions with Platform & by Email
PARTICIPANTS
Unique # Participated
VALIDATIONS
Responses Validated*
DATA ROOM
EXECUTIVE
CITATIONS
COMPANY
DISCUSSIONS
BRAND/PRODUCT
INSIGHTS
TOTAL
DATA STACK
*Clients have full access to our data room
DATE
SEP 2023
COMPANIES
77
TABLES
123
PAGES
489
EDITION
22
PRICE
USD 5600
CODE
MCP-1093
*Engagement stats are ongoing and dynamic
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- $500/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- $1000/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- $2500/Month/User. Extra Users @ $150/Month/User
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
What`s New?
» Special discussions on the global economic climate and market sentiment
» Coverage on global competitiveness and key competitor percentage market shares
» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass™ research platform
» Complimentary updates for one year
» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Economic Outlook
The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.
The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Automated and Rapid Microbiological Tests Market to Reach $10 Billion by 2030
The global market for Automated and Rapid Microbiological Tests estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$10 Billion by 2030, growing at aCAGR of 6.7% over the period 2022-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Aiss (clinical) segment is estimated at 3.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 9.2% CAGR
The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$2.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 6.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.
SELECT PLAYERS
3M Company; Abbott Laboratories, Inc.; Becton, Dickinson and Company; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; bioMerieux SA; Abbott Molecular, Inc.; American Type Culture Collection (ATCC); Biocartis NV; Biomerica, Inc.; AutoGenomics, Inc.; BioControl Systems, Inc.; BioFire Diagnostics LLC; BIT Analytical Instruments GmbH; Biosystems S.A.
SEGMENTS
» Application (GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical), Non-Clinical)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of COVID-19 Pandemic and Looming Global Recession |
EXHIBIT: Clinical Microbiology Gains Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: COVID-19 Tests Per Million Population by Country (As of 15 June 2021) |
A New, 20-Minute Assay for COVID-19 Diagnosis |
Automated and Rapid Microbiological Tests – Global Key Competitors Percentage Market Share in 2022 (E) |
Automated and Rapid Microbiological Tests: An Introduction |
Enabling Technologies of Automated & Rapid Microbiological Tests |
Clinical Applications of Automated & Rapid Microbiological Tests |
Applications in Non-Clinical Investigations |
Global Market Prospects & Outlook |
Evolutionary Battle against Microbes Drives Market Future |
Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing |
Developed Regions Lead, Developing Economies to Boost Future Growth |
Competition |
Recent Market Activity |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Rapid Diagnostics Bring in a Transformation to Clinical Testing Practices |
Traditional Rapid Microbiological Tests Make Way for New, Probe Tests |
Lab Automation Trend Augurs Well for Microbiological Testing Labs |
Traditional Approaches Give Way to Modern Automated Microbiology Systems |
Microbiology Laboratories Switch to Automation to Push Yields |
Growing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing |
EXHIBIT: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %) |
EXHIBIT: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %) |
Rising Prevalence of Respiratory Infections Drive Market Growth |
EXHIBIT: Global Number of Deaths Caused Due to Communicable Diseases (In 000s) |
Rise in Prevalence of COPD Augments Demand |
EXHIBIT: Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group |
Influenza Boosts Rapid Test Prospects |
EXHIBIT: Flu Related CDC Estimates from October 2019-April 2020 |
Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests |
EXHIBIT: Percentage Share Breakdown of Global Deaths Linked to Air Pollution |
EXHIBIT: Most Polluted Countries Worldwide: Average PM2.5 concentration (μg/m³) for 2020 |
Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing |
EXHIBIT: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020 |
EXHIBIT: Number of AIDS-Related Deaths (in Thousands) by Region for 2018 |
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease |
Home HIV Testing Emerges as a Lucrative Option |
Advancements in Molecular Diagnostics Drive Market Growth |
Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis |
Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia |
Advancements in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market |
Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests |
Healthcare Needs of the World’s Aging Population: Potential Opportunity in Store |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 |
Increase in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
EXHIBIT: Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050 |
Clinical Microbiology Market Benefits from Digitalization and Robotization Trend |
Integration of Clinical Microbiology with Cloud Computing |
Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology |
Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential… |
Technological Advancements to Drive the Automated Microbiology Testing Market |
Focus on Safe and High-Quality Foods Propels Rapid Microbiological Testing |
EXHIBIT: Number of Food Allergen Recalls in the US: Breakdown by FDA-Regulated Foods and FSIS-Regulated Foods for 2019 |
Foodborne Illness Outbreak Investigations in the US (2019 & 2020) |
Impact of COVID-19 on Food Safety Testing Industry |
Stringent Norms Necessitate Food Safety Testing |
Food Microbiology Testing Market on a Growth Spree |
EXHIBIT: Global Food Safety Testing Market Breakdown (in %) by Segment for 2020 |
Rapid and Automated Tests Emerge as an Attractive Solution |
Leading Food Processors Exhibit Inclination Towards Rapid Microbiological Testing |
Automation of Food Microbiology Labs |
Poultry Industry Embraces Rapid Microbiological Testing Technologies |
Rapid Microbial Testing in Dairy Industry |
Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing |
Technical and Cost Related Hurdles Hamper the Microbiology Testing Market |
Rapid Microbiological Testing Gains Significance in the Pharmaceutical Industry |
Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry |
Growing Importance of Rapid Microbiological Testing for Pharma Laboratories |
Key RMM Technologies for Pharmaceutical Industry |
Adoption of Rapid Methods for QC Microbiology in Biopharmaceuticals |
Advancements in Rapid Microbiological Testing for Pharmaceutical Industry |
Rapid Microbial Testing for Regenerative Medicine: An Emerging Space |
Rapid Microbiological Methods and the Regulatory Environment in Drug Development Industry |
FDA’s Requirements for Validation of RMM |
EMA’s Guidance on Use of RMMs for Water Testing |
Rapid Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies |
Antibiotic Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools |
Antimicrobial Vulnerability Testing and Identification of Microbial strains |
Role of Microscopy in Antimicrobial Susceptibility Testing |
Rising Prominence of NAAT-Driven AST |
Economic Factors Promise Growth for Rapid AST |
Rapid Technologies Gain Momentum in Environment Testing Field |
Deteriorating Quality of Water Throws Emphasis on Water Testing Services |
EXHIBIT: Percentage of Contaminated Water in Drinking Water Supplies in Africa, Asia, and Latin America and Caribbean |
Key Issues Confronting the Rapid Microbiological Tests Market |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for GC/CRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for AISS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for ABCS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for SIRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for ATS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Applications (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Non-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Automated and Rapid Microbiological Tests Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
Rising Threat of Infectious Diseases Drive Significance of Rapid Microbiological Testing |
EXHIBIT: Healthcare Spending as a % of GDP in the US: 2010-2020 |
COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests |
US-based Labs Ramp Up Operations Amidst the COVID-19 Situation |
Unmet Diagnostic Needs of Aging Population: Major Driver |
EXHIBIT: US Elderly Population: Expected Growth Rates Over the Years 2005-2025 |
EXHIBIT: North American Aging Population by Age Group: 1975-2050 |
Select Product Categories in Rapid Microbiological Testing – An Overview |
Automated Susceptibility Testing Systems |
STD Rapid Tests |
Respiratory Rapid Tests |
Streptococcus Infection Rapid Tests |
Food Safety Microbiological Testing Market: Concerns over Food Safety Drive Market Gains |
EXHIBIT: Foodborne Illnesses, Hospitalizations and Deaths in the US: Percentage Breakdown for Known Pathogens and Unspecified Agents |
EXHIBIT: Leading Pathogens Causing Foodborne Illnesses in the US: Percentage Breakdown of Number of Illnesses by Known Pathogens |
EXHIBIT: Number of Food Recalls in the US: Breakdown by Class I Recalls and Class II & III Recalls for 2014-2019 |
USA Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
JAPAN |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Market Overview |
EXHIBIT: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025 |
COVID-19 Testing Market In Japan |
Japan Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
CHINA |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
Market Overview |
COVID-19 Testing Market |
China Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
EUROPE |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
COVID-19 Pandemic Propels Demand for Rapid Microbiological Testing |
Growth in Clinical Diagnostics Automation |
Rise in Automated and Rapid Tests in Clinical Applications |
Aging Demography: An Opportunity Indicator |
Food Safety Testing Market in Europe: An Overview |
Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
FRANCE |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
GERMANY |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Market Overview |
Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
AUSTRALIA |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E) |
Australia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Australia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Australia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
INDIA |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E) |
Market Overview |
Demand for Automated and Rapid Microbiology Testing Poised for Growth |
Automation – Name of the Game |
Private Enterprises Encourage Changes in Diagnostics Sector |
India Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
India Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
India 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
South Korea Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
South Korea 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
LATIN AMERICA |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E) |
Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030 |
Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
ARGENTINA |
Argentina Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Argentina Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Argentina 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
BRAZIL |
Brazil Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Brazil Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Brazil 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
MEXICO |
Mexico Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Mexico Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Mexico 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
REST OF LATIN AMERICA |
Rest of Latin America Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Latin America 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
MIDDLE EAST |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E) |
Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Middle East Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030 |
Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
IRAN |
Iran Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Iran Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Iran 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
ISRAEL |
Israel Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Israel Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Israel 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
SAUDI ARABIA |
Saudi Arabia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Saudi Arabia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Saudi Arabia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
UNITED ARAB EMIRATES |
UAE Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UAE Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UAE 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
REST OF MIDDLE EAST |
Rest of Middle East Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Middle East 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
AFRICA |
Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E) |
Africa Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.